Canadian intraoperative MRI developer IMRIS of Winnipeg, Manitoba, has launched a five-year research initiative that will focus on the development and marketing of MR-guided radiation therapy and interventional procedures.
In collaboration with the University Health Network (UHN) of Toronto, IMRIS will research and test image-guided radiation therapy at UHN's Princess Margaret Hospital with its 3-tesla MR. Planned applications include the integration of IMRIS' technology with external-beam radiation therapy, MR-guided biopsies, and brachytherapy of the prostate, IMRIS said.
Related Reading
IMRIS signs Yale, January 13, 2009
IMRIS takes first Australian order, January 7, 2009
IMRIS nets FDA OK for 3T MRI, December 19, 2008
IMRIS names Rice to U.S. sales post, May 30, 2008
Copyright © 2009 AuntMinnie.com
